Sibel and LookDeep Partner on Bedside AI
Sibel Health and LookDeep Health have formed a strategic partnership to combine continuous vital sign monitoring with real-time, bedside artificial intelligence. The collaboration is designed to deliver AI-driven clinical insights without vendor lock-in, integrating with existing hospital workflows and devices. This reflects a growing trend of deploying AI at the point of care.
- Sibel Health, a Northwestern University spin-out, recently secured a $30 million Series C funding round and its seventh FDA 510(k) clearance for its ANNE One platform, which enables alarms and a central monitoring station for its wearable sensors. - A key clinical driver for this technology is the limitation of intermittent vital sign checks, which are typically done every 4-8 hours; one propensity-matched study found that patients with intermittent monitoring had nearly three times greater odds of ICU admission or in-hospital mortality compared to those with continuous monitoring. - LookDeep Health's AI platform utilizes computer vision and has already been deployed across 11 hospitals in one health network to monitor high-risk patients for falls and to help prevent workplace violence by detecting escalating tensions in a room. - The partnership's emphasis on avoiding "vendor lock-in" addresses a major industry pain point, as large healthcare organizations can spend $15-20 million annually on software support alone, and 60-80% of a hospital's IT budget can be consumed by maintaining legacy systems. [cite:
